Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia (QUATRO)

Wandercraft

Status: Completed

Conditions: Paraplegia, Complete; Paraplegia, Incomplete; Tetraplegia/Tetraparesis; Guillain Barré Syndrome; Spinal Cord Injury

Treatments: Device: Hands-free exoskeleton

Study type: Observational

Funder types: Industry

Identifiers

NCT06939634

CIP009

Details and patient eligibility

About

The objective of this clinical trial is to determine whether the Atalante X exoskeleton can be safely utilized by patients with tetraplegia and high paraplegia (at or above T4).

Enrollment: 35 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ≥18 years old,
• Tetraplegia or high paraplegia (at or above T4) regardless of the cause,
• Non-opposition to the participation to the study,
• Having undergone a minimum of 1 session with the Atalante device from February 2019, to now.

Exclusion criteria

• Neurological Level of Injury below T4 as determined by the International Standards for Neurological Classification of SCI

Trial design

35 participants in 1 patient group

Hands-free exoskeleton

Description:

Patient with high paraplegia or tetraplegia who have undergone at least one session with the exoskeleton.

Treatment:

Device: Hands-free exoskeleton